AMIODARONE HYDROCHLORIDE

AMIODARONE HYDROCHLORIDE was reported 11366 times

AMIODARONE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 APPENDICOLITH 209 0.5401
1 SLEEP DISORDER THERAPY 103 0.5202
2 ANTACID THERAPY 61 0.4692
3 FEMORAL HERNIA INCARCERATED 27 0.3750
4 ANALGESIC THERAPY 110 0.3427
5 DRUG THERAPY 104 0.3068
6 LYMPHATIC FISTULA 27 0.2700
7 CONGENITAL HIATUS HERNIA 60 0.2632
8 MALIGNANT MELANOMA STAGE 0 50 0.2392
9 ANTICOAGULANT THERAPY 60 0.2113
10 ELECTROCARDIOGRAM T WAVE ALTERNANS 8 0.1860
11 BACTEROIDES INFECTION 35 0.1341
12 INFUSION SITE PHLEBITIS 28 0.1228
13 MYXOEDEMA COMA 32 0.1049
14 ARRHYTHMIC STORM 33 0.0988
15 DEPOSIT EYE 26 0.0970
16 PANCREATIC STEATOSIS 23 0.0846
17 WOUND INFECTION PSEUDOMONAS 26 0.0831
18 DECOMPENSATED HYPOTHYROIDISM 10 0.0741
19 HYPERPHOSPHATAEMIA 126 0.0586
20 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 54 0.0583
21 PULMONARY TOXICITY 411 0.0581
22 BLOOD PHOSPHORUS INCREASED 151 0.0553
23 THYROTOXIC CRISIS 60 0.0527
24 CONGESTIVE HEPATOPATHY 21 0.0469
25 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 17 0.0447
26 ENDOMETRIAL DISORDER 17 0.0412
27 DEVICE WIRELESS COMMUNICATION ISSUE 9 0.0347
28 LYMPHOID TISSUE HYPERPLASIA 10 0.0282
29 CORNEAL DEPOSITS 21 0.0282
30 THYROXINE FREE INCREASED 17 0.0266
31 VENTRICULAR FIBRILLATION 293 0.0264
32 ARTERIAL HAEMORRHAGE 30 0.0262
33 ENTEROCOCCUS TEST POSITIVE 17 0.0262
34 HYPERTHYROIDISM 365 0.0252
35 EOSINOPHILIC PNEUMONIA ACUTE 20 0.0231
36 APPENDICITIS 215 0.0230
37 CARDIOGENIC SHOCK 325 0.0226
38 TOTAL LUNG CAPACITY DECREASED 36 0.0225
39 IRON DEFICIENCY 101 0.0224
40 AORTIC STENOSIS 77 0.0221
41 BLOOD URIC ACID INCREASED 126 0.0218
42 JUGULAR VEIN DISTENSION 12 0.0212
43 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 105 0.0207
44 PULMONARY FIBROSIS 396 0.0206
45 SEROMA 26 0.0204
46 DEPENDENCE ON OXYGEN THERAPY 10 0.0203
47 PSEUDOMONAL BACTERAEMIA 17 0.0199
48 ALVEOLITIS 28 0.0198
49 KERATOPATHY 31 0.0196
50 MYASTHENIA GRAVIS 157 0.0194
51 HYPOPHOSPHATAEMIA 142 0.0192
52 PLEURITIC PAIN 52 0.0188
53 AORTIC VALVE STENOSIS 33 0.0185
54 PERIPHERAL SENSORIMOTOR NEUROPATHY 23 0.0183
55 TORSADE DE POINTES 142 0.0181
56 LUNG OPACITY 47 0.0178
57 SINUS NODE DYSFUNCTION 32 0.0175
58 THYROIDITIS 51 0.0170
59 RESPIRATORY SYMPTOM 47 0.0165
60 DYSPNOEA PAROXYSMAL NOCTURNAL 12 0.0165
61 ACUTE LEFT VENTRICULAR FAILURE 11 0.0164
62 OPTIC NERVE INJURY 19 0.0164
63 NODAL ARRHYTHMIA 14 0.0163
64 TROPONIN INCREASED 123 0.0162
65 BRASH SYNDROME 22 0.0157
66 DEVICE MAINTENANCE ISSUE 9 0.0153
67 TACHYARRHYTHMIA 37 0.0148
68 OPTIC NEUROPATHY 31 0.0146
69 VENTRICULAR TACHYCARDIA 219 0.0132
70 ELECTROCARDIOGRAM PR PROLONGATION 10 0.0131
71 CARDIAC AMYLOIDOSIS 14 0.0127
72 NODAL RHYTHM 18 0.0123
73 ATRIAL TACHYCARDIA 25 0.0119
74 CHRONIC RESPIRATORY FAILURE 14 0.0116
75 BREATH SOUNDS ABNORMAL 57 0.0115
76 NEUROMYOPATHY 12 0.0113
77 CARDIAC FAILURE CHRONIC 48 0.0113
78 MULTIPLE ORGAN DYSFUNCTION SYNDROME 317 0.0112
79 VENTRICULAR ARRHYTHMIA 39 0.0107
80 BENIGN PROSTATIC HYPERPLASIA 55 0.0106
81 HALO VISION 12 0.0106
82 LONG QT SYNDROME 24 0.0100
83 ATRIAL FLUTTER 79 0.0099
84 CONDUCTION DISORDER 18 0.0098
85 AORTIC ARTERIOSCLEROSIS 25 0.0097
86 OPTIC ISCHAEMIC NEUROPATHY 37 0.0095
87 MYELOPATHY 18 0.0095
88 HEPATIC CYST 32 0.0094
89 ASCITES 277 0.0094
90 ORTHOPNOEA 30 0.0094
91 BUNDLE BRANCH BLOCK LEFT 39 0.0092
92 IMPLANTABLE DEFIBRILLATOR INSERTION 12 0.0091
93 MITRAL VALVE INCOMPETENCE 101 0.0089
94 DILATED CARDIOMYOPATHY 9 0.0089
95 HYPERLIPIDAEMIA 106 0.0089
96 TRAUMATIC LUNG INJURY 17 0.0088
97 BLOOD CALCIUM INCREASED 77 0.0088
98 ATRIOVENTRICULAR BLOCK FIRST DEGREE 38 0.0088
99 DIFFUSE ALVEOLAR DAMAGE 10 0.0087
100 LEFT VENTRICULAR DYSFUNCTION 57 0.0085
101 DEVICE INFUSION ISSUE 21 0.0085
102 CARDIOACTIVE DRUG LEVEL INCREASED 11 0.0084
103 HAEMORRHAGIC DISORDER 9 0.0083
104 THYROID DISORDER 127 0.0082
105 BLINDNESS 329 0.0081
106 COORDINATION ABNORMAL 112 0.0080
107 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 137 0.0080
108 BACTERIAL INFECTION 149 0.0080
109 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 11 0.0078
110 SICK SINUS SYNDROME 9 0.0078
111 PERICARDIAL HAEMORRHAGE 17 0.0078
112 ESSENTIAL HYPERTENSION 14 0.0076
113 EOSINOPHILIC PNEUMONIA 24 0.0076
114 INTERMITTENT CLAUDICATION 12 0.0076
115 TRICUSPID VALVE INCOMPETENCE 60 0.0075
116 HYPERVOLAEMIA 37 0.0075
117 THYROID FUNCTION TEST ABNORMAL 31 0.0075
118 INFUSION SITE DISCHARGE 13 0.0074
119 EJECTION FRACTION DECREASED 114 0.0073
120 ARRHYTHMIA SUPRAVENTRICULAR 8 0.0073
121 PULMONARY ALVEOLAR HAEMORRHAGE 41 0.0073
122 CARDIOVERSION 10 0.0072
123 FIBROSIS 22 0.0071
124 DIVERTICULUM INTESTINAL 31 0.0071
125 LEFT ATRIAL DILATATION 9 0.0071
126 RALES 41 0.0071
127 READING DISORDER 16 0.0070
128 SINUS BRADYCARDIA 67 0.0069
129 END STAGE RENAL DISEASE 126 0.0069
130 THERAPEUTIC AGENT TOXICITY 23 0.0069
131 NEURALGIA 167 0.0069
132 DILATATION ATRIAL 8 0.0069
133 RESTRICTIVE PULMONARY DISEASE 8 0.0068
134 WOUND DEHISCENCE 23 0.0068
135 PULMONARY HYPERTENSION 141 0.0068
136 CARDIAC FAILURE ACUTE 45 0.0067
137 ATRIOVENTRICULAR BLOCK COMPLETE 45 0.0067
138 CARDIAC ABLATION 12 0.0067
139 GOUT 120 0.0067
140 BLOOD PRESSURE DIASTOLIC ABNORMAL 17 0.0067
141 ELECTROCARDIOGRAM QT PROLONGED 239 0.0066
142 HYPONATRAEMIA 371 0.0066
143 ISCHAEMIC HEPATITIS 9 0.0066
144 HYPOTHYROIDISM 210 0.0066
145 ATRIAL FIBRILLATION 639 0.0066
146 HYPERCHOLESTEROLAEMIA 63 0.0065
147 ELECTROCARDIOGRAM T WAVE ABNORMAL 10 0.0064
148 PULSELESS ELECTRICAL ACTIVITY 26 0.0062
149 DILATATION VENTRICULAR 13 0.0062
150 BRAIN NATRIURETIC PEPTIDE INCREASED 19 0.0062
151 DIASTOLIC DYSFUNCTION 19 0.0061
152 HAEMORRHAGIC ANAEMIA 27 0.0061
153 VENTRICULAR EXTRASYSTOLES 63 0.0061
154 NEPHROGENIC ANAEMIA 28 0.0060
155 ISCHAEMIC CARDIOMYOPATHY 18 0.0059
156 GOITRE 24 0.0059
157 RHONCHI 8 0.0058
158 ULCER 92 0.0058
159 VENTRICULAR DYSFUNCTION 15 0.0058
160 INFUSION SITE HAEMORRHAGE 19 0.0058
161 CARDIOMEGALY 71 0.0058
162 ADRENAL INSUFFICIENCY 70 0.0058
163 ECHOCARDIOGRAM ABNORMAL 8 0.0057
164 PHLEBITIS 29 0.0057
165 ASPIRATION 62 0.0057
166 ACUTE HEPATIC FAILURE 77 0.0056
167 INTERSTITIAL LUNG DISEASE 272 0.0056
168 WHEEZING 329 0.0055
169 PULMONARY VALVE INCOMPETENCE 8 0.0055
170 INFLAMMATORY MARKER INCREASED 27 0.0054
171 CORONARY ARTERY DISEASE 164 0.0054
172 BLOOD TEST ABNORMAL 76 0.0054
173 INFUSION SITE PAIN 68 0.0053
174 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 8 0.0052
175 MICTURITION DISORDER 18 0.0052
176 VITREOUS FLOATERS 51 0.0052
177 HYPERTROPHIC CARDIOMYOPATHY 8 0.0052
178 FAECALOMA 28 0.0051
179 ACUTE RESPIRATORY FAILURE 98 0.0051
180 BRADYCARDIA 269 0.0051
181 VENTRICULAR HYPOKINESIA 16 0.0050
182 AORTIC VALVE INCOMPETENCE 21 0.0049
183 FULL BLOOD COUNT ABNORMAL 52 0.0049
184 CARDIOVASCULAR INSUFFICIENCY 8 0.0049
185 RESPIRATORY FAILURE 358 0.0049
186 CARDIAC VALVE DISEASE 28 0.0049
187 CHEST X-RAY ABNORMAL 15 0.0049
188 BRADYARRHYTHMIA 8 0.0049
189 LUNG INFILTRATION 43 0.0049
190 COLONIC POLYP 8 0.0048
191 APLASTIC ANAEMIA 25 0.0048
192 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 249 0.0048
193 INFUSION SITE SWELLING 30 0.0048
194 MULTIPLE INJURIES 30 0.0048
195 INFUSION SITE INFECTION 11 0.0047
196 MICTURITION URGENCY 53 0.0046
197 LACUNAR INFARCTION 11 0.0046
198 PRODUCT PACKAGING CONFUSION 11 0.0045
199 INFUSION SITE ERYTHEMA 38 0.0045
200 JOINT EFFUSION 31 0.0045
201 SUPRAVENTRICULAR EXTRASYSTOLES 15 0.0044
202 VISUAL FIELD DEFECT 32 0.0044
203 CARDIAC FAILURE CONGESTIVE 355 0.0044
204 KOUNIS SYNDROME 10 0.0044
205 MYOPATHY 38 0.0044
206 PROTHROMBIN TIME PROLONGED 26 0.0043
207 BLOOD CULTURE POSITIVE 13 0.0043
208 LUNG DISORDER 212 0.0043
209 INTERNATIONAL NORMALISED RATIO INCREASED 122 0.0043
210 ESCHERICHIA INFECTION 35 0.0043
211 HAEMARTHROSIS 38 0.0042
212 MECHANICAL VENTILATION 8 0.0042
213 LEFT VENTRICULAR HYPERTROPHY 18 0.0042
214 ACUTE RESPIRATORY DISTRESS SYNDROME 74 0.0042
215 ANURIA 36 0.0042
216 ARRHYTHMIA 193 0.0041
217 LEFT VENTRICULAR FAILURE 14 0.0041
218 ORGANISING PNEUMONIA 20 0.0040
219 CARDIAC DYSFUNCTION 15 0.0040
220 ATRIOVENTRICULAR BLOCK 31 0.0040
221 BRONCHIECTASIS 27 0.0040
222 POSTOPERATIVE WOUND INFECTION 27 0.0040
223 BLOOD LOSS ANAEMIA 9 0.0040
224 NEPHROPATHY 37 0.0040
225 EYE INJURY 12 0.0039
226 HEART RATE ABNORMAL 22 0.0039
227 DYSPNOEA EXERTIONAL 148 0.0039
228 BUNDLE BRANCH BLOCK RIGHT 18 0.0039
229 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 20 0.0039
230 EXTRAVASATION 16 0.0039
231 OEDEMA 211 0.0039
232 HEPARIN-INDUCED THROMBOCYTOPENIA 19 0.0039
233 HEART RATE IRREGULAR 87 0.0038
234 WEIGHT FLUCTUATION 40 0.0038
235 CARDIAC FAILURE 306 0.0038
236 HAEMODYNAMIC INSTABILITY 29 0.0038
237 DYSPNOEA AT REST 11 0.0038
238 COAGULOPATHY 63 0.0038
239 GROIN PAIN 33 0.0038
240 BLOOD POTASSIUM ABNORMAL 10 0.0037
241 BLOOD THYROID STIMULATING HORMONE DECREASED 17 0.0037
242 CAROTID ARTERY STENOSIS 13 0.0037
243 RIGHT VENTRICULAR FAILURE 26 0.0037
244 HEPATITIS FULMINANT 11 0.0037
245 ECONOMIC PROBLEM 56 0.0037
246 IRON DEFICIENCY ANAEMIA 34 0.0037
247 SUPRAVENTRICULAR TACHYCARDIA 35 0.0037
248 EXERCISE TOLERANCE DECREASED 21 0.0036
249 ATRIOVENTRICULAR BLOCK SECOND DEGREE 11 0.0036
250 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 12 0.0036
251 UNEVALUABLE EVENT 274 0.0036
252 HYPERKALAEMIA 126 0.0036
253 BLOOD THYROID STIMULATING HORMONE INCREASED 33 0.0036
254 CARDIOMYOPATHY 53 0.0036
255 HYPOXIA 126 0.0036
256 CARDIAC TAMPONADE 17 0.0036
257 LUNG CONSOLIDATION 10 0.0036
258 TRANSAMINASES INCREASED 79 0.0035
259 LOWER GASTROINTESTINAL HAEMORRHAGE 26 0.0035
260 HAEMOGLOBIN INCREASED 16 0.0035
261 ECCHYMOSIS 24 0.0035
262 JOINT DISLOCATION 37 0.0035
263 HAEMOTHORAX 10 0.0034
264 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 9 0.0034
265 CONGESTIVE CARDIOMYOPATHY 14 0.0034
266 INFUSION SITE REACTION 10 0.0033
267 LISTLESS 11 0.0033
268 ARTERIOSCLEROSIS CORONARY ARTERY 22 0.0033
269 GENERAL PHYSICAL HEALTH DETERIORATION 383 0.0033
270 PERIPHERAL VASCULAR DISORDER 17 0.0033
271 POTENTIATING DRUG INTERACTION 11 0.0033
272 BRONCHITIS CHRONIC 8 0.0033
273 CARDIOVASCULAR DISORDER 83 0.0033
274 RETROPERITONEAL HAEMORRHAGE 8 0.0032
275 ACUTE PULMONARY OEDEMA 18 0.0032
276 SEPSIS 356 0.0032
277 PLEURAL EFFUSION 194 0.0032
278 CARDIAC PACEMAKER INSERTION 19 0.0032
279 PULMONARY CONGESTION 42 0.0032
280 RETINAL ARTERY OCCLUSION 8 0.0032
281 RHINITIS ALLERGIC 14 0.0031
282 JOINT INJURY 67 0.0031
283 CARDIAC MURMUR 27 0.0031
284 ATELECTASIS 30 0.0031
285 CONCOMITANT DISEASE AGGRAVATED 19 0.0031
286 BLOOD PRESSURE SYSTOLIC DECREASED 14 0.0031
287 DRUG-INDUCED LIVER INJURY 96 0.0031
288 ELECTROCARDIOGRAM ABNORMAL 24 0.0031
289 DRUG INTERACTION 483 0.0030
290 BLOOD CHOLESTEROL INCREASED 140 0.0030
291 HYPERAMMONAEMIA 15 0.0030
292 GENERALISED OEDEMA 37 0.0030
293 HEPATITIS CHOLESTATIC 18 0.0030
294 CATHETERISATION CARDIAC 13 0.0029
295 RENAL FAILURE CHRONIC 22 0.0029
296 GASTROINTESTINAL HAEMORRHAGE 239 0.0029
297 NYSTAGMUS 15 0.0028
298 HAEMORRHAGIC STROKE 22 0.0028
299 PRODUCT USE IN UNAPPROVED INDICATION 697 0.0028
300 PULMONARY OEDEMA 125 0.0028
301 KLEBSIELLA INFECTION 14 0.0028
302 ARTERIOSCLEROSIS 26 0.0028
303 HIATUS HERNIA 35 0.0027
304 ASTHENIA 1016 0.0027
305 RENAL FAILURE ACUTE 114 0.0027
306 MYOCLONUS 32 0.0027
307 NEUROTOXICITY 47 0.0027
308 PNEUMONITIS 73 0.0027
309 CEREBRAL HAEMATOMA 9 0.0027
310 METABOLIC ENCEPHALOPATHY 8 0.0027
311 ABDOMINAL DISTENSION 275 0.0026
312 INTERNATIONAL NORMALISED RATIO ABNORMAL 9 0.0026
313 THYROID MASS 10 0.0026
314 NERVE COMPRESSION 24 0.0026
315 THROMBOSIS 209 0.0026
316 DIZZINESS POSTURAL 25 0.0026
317 HYPOTENSION 517 0.0026
318 DYSLIPIDAEMIA 13 0.0026
319 EMBOLIC STROKE 9 0.0026
320 DIABETES MELLITUS 194 0.0025
321 ENDOCARDITIS 13 0.0025
322 TRANSIENT ISCHAEMIC ATTACK 85 0.0025
323 STREPTOCOCCAL INFECTION 14 0.0025
324 ODYNOPHAGIA 15 0.0025
325 PULMONARY FUNCTION TEST DECREASED 11 0.0025
326 HAEMOPTYSIS 70 0.0025
327 BLOOD CREATININE INCREASED 162 0.0025
328 CHOLECYSTITIS ACUTE 14 0.0025
329 BLOOD POTASSIUM INCREASED 40 0.0025
330 HYPERTRANSAMINASAEMIA 17 0.0024
331 VASCULAR DEVICE INFECTION 11 0.0024
332 DIABETIC NEUROPATHY 12 0.0024
333 HYPERNATRAEMIA 12 0.0024
334 RED CELL DISTRIBUTION WIDTH INCREASED 10 0.0024
335 PEMPHIGOID 18 0.0024
336 HAEMATURIA 81 0.0024
337 RENAL TUBULAR NECROSIS 23 0.0023
338 SLEEP DISORDER 165 0.0023
339 BLOOD UREA INCREASED 39 0.0023
340 PANIC DISORDER 9 0.0023
341 FAILURE TO THRIVE 12 0.0023
342 LOWER RESPIRATORY TRACT INFECTION 105 0.0023
343 ANGINA UNSTABLE 15 0.0023
344 HEART RATE DECREASED 81 0.0023
345 DRY MOUTH 187 0.0023
346 STAPHYLOCOCCAL BACTERAEMIA 10 0.0023
347 HYPOKALAEMIA 105 0.0023
348 OLIGURIA 14 0.0023
349 HAEMORRHOIDAL HAEMORRHAGE 11 0.0023
350 CARDIAC ARREST 185 0.0022
351 COUGH 627 0.0022
352 ANAEMIA 426 0.0022
353 HYPOMAGNESAEMIA 31 0.0022
354 UPPER GASTROINTESTINAL HAEMORRHAGE 37 0.0022
355 LIVER FUNCTION TEST INCREASED 47 0.0022
356 INTESTINAL ISCHAEMIA 12 0.0022
357 ISCHAEMIA 10 0.0022
358 INCREASED TENDENCY TO BRUISE 20 0.0022
359 DYSPNOEA 1229 0.0022
360 SUBDURAL HAEMATOMA 31 0.0022
361 DRUG INTOLERANCE 208 0.0022
362 SYNCOPE 215 0.0021
363 HEPATIC ENCEPHALOPATHY 20 0.0021
364 RESTLESSNESS 78 0.0021
365 ORTHOSTATIC HYPOTENSION 37 0.0021
366 INTENTIONAL PRODUCT MISUSE 186 0.0021
367 ACUTE KIDNEY INJURY 324 0.0021
368 SKIN LACERATION 23 0.0021
369 MYOCARDIAL ISCHAEMIA 24 0.0021
370 OSTEOPENIA 32 0.0021
371 INJECTION SITE EXTRAVASATION 26 0.0021
372 ATAXIA 25 0.0021
373 PULMONARY EMBOLISM 199 0.0021
374 SHOCK HAEMORRHAGIC 17 0.0021
375 LIVER INJURY 51 0.0021
376 CHEST PAIN 383 0.0021
377 LIVER DISORDER 91 0.0020
378 SHOCK 47 0.0020
379 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 18 0.0020
380 OEDEMA PERIPHERAL 248 0.0020
381 PERICARDIAL EFFUSION 47 0.0020
382 SWELLING 190 0.0020
383 NERVOUSNESS 106 0.0020
384 HEPATIC CIRRHOSIS 38 0.0020
385 PRESYNCOPE 49 0.0020
386 PRODUCT PRESCRIBING ERROR 48 0.0020
387 RENAL CYST 16 0.0020
388 PULMONARY MASS 30 0.0020
389 CEREBRAL ATROPHY 8 0.0020
390 MELAENA 44 0.0020
391 BLOOD POTASSIUM DECREASED 60 0.0020
392 HEPATOTOXICITY 44 0.0020
393 TOXIC EPIDERMAL NECROLYSIS 30 0.0020
394 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 8 0.0020
395 SPINAL STENOSIS 8 0.0019
396 SPINAL OSTEOARTHRITIS 17 0.0019
397 ACUTE CORONARY SYNDROME 16 0.0019
398 RESPIRATORY DISTRESS 53 0.0019
399 PULMONARY HAEMORRHAGE 15 0.0019
400 GAIT DISTURBANCE 363 0.0019
401 HAEMATOCRIT DECREASED 37 0.0019
402 SINUS HEADACHE 11 0.0018
403 HEPATITIS ACUTE 12 0.0018
404 ENCEPHALOPATHY 45 0.0018
405 PNEUMOTHORAX 29 0.0018
406 RENAL INJURY 54 0.0018
407 MUSCLE ATROPHY 23 0.0018
408 HAEMATOMA 47 0.0018
409 DRUG LEVEL INCREASED 30 0.0018
410 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 14 0.0018
411 MYELODYSPLASTIC SYNDROME 26 0.0018
412 PULMONARY ARTERIAL HYPERTENSION 26 0.0018
413 SEPTIC SHOCK 78 0.0018
414 SPUTUM DISCOLOURED 17 0.0018
415 PAPILLOEDEMA 8 0.0018
416 HEPATIC FUNCTION ABNORMAL 66 0.0018
417 PNEUMONIA 572 0.0018
418 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 18 0.0018
419 FLUID RETENTION 89 0.0017
420 RENAL IMPAIRMENT 147 0.0017
421 PSEUDOMONAS INFECTION 15 0.0017
422 SKIN NECROSIS 9 0.0017
423 UROSEPSIS 16 0.0017
424 RENAL FAILURE 230 0.0017
425 ASPARTATE AMINOTRANSFERASE INCREASED 92 0.0017
426 DECUBITUS ULCER 14 0.0017
427 BLOOD PRESSURE DECREASED 114 0.0017
428 OXYGEN SATURATION DECREASED 96 0.0017
429 MENTAL STATUS CHANGES 47 0.0017
430 GLUCOSE TOLERANCE IMPAIRED 10 0.0017
431 HYPOGLYCAEMIA 82 0.0017
432 PLEURISY 10 0.0017
433 PULSE ABSENT 8 0.0017
434 MULTI-ORGAN FAILURE 29 0.0017
435 HYPOVOLAEMIC SHOCK 8 0.0017
436 ARTERIAL OCCLUSIVE DISEASE 13 0.0017
437 ERUCTATION 32 0.0017
438 CONSTIPATION 358 0.0016
439 QUALITY OF LIFE DECREASED 22 0.0016
440 DISSEMINATED INTRAVASCULAR COAGULATION 23 0.0016
441 RESPIRATORY DEPRESSION 20 0.0016
442 DISTURBANCE IN ATTENTION 88 0.0016
443 HEPATOMEGALY 16 0.0016
444 GLOMERULAR FILTRATION RATE DECREASED 20 0.0016
445 HEPATIC FAILURE 49 0.0016
446 GAMMA-GLUTAMYLTRANSFERASE INCREASED 36 0.0016
447 TOXICITY TO VARIOUS AGENTS 272 0.0016
448 BLOOD BILIRUBIN INCREASED 43 0.0016
449 CORONARY ARTERY STENOSIS 8 0.0016
450 DELIRIUM 55 0.0016
451 RHABDOMYOLYSIS 66 0.0016
452 UPPER RESPIRATORY TRACT INFECTION 73 0.0016
453 EXTRASYSTOLES 11 0.0016
454 TREMOR 261 0.0016
455 SLEEP APNOEA SYNDROME 30 0.0016
456 CORONARY ARTERY BYPASS 9 0.0016
457 SEASONAL ALLERGY 22 0.0016
458 TEMPERATURE INTOLERANCE 16 0.0015
459 CARDIAC FLUTTER 10 0.0015
460 PELVIC FRACTURE 12 0.0015
461 EOSINOPHILIA 27 0.0015
462 HAEMORRHAGE INTRACRANIAL 23 0.0015
463 HYPOVOLAEMIA 9 0.0015
464 ABDOMINAL PAIN 356 0.0015
465 BLOOD ALKALINE PHOSPHATASE INCREASED 38 0.0015
466 PRODUCT ADMINISTRATION INTERRUPTED 12 0.0015
467 OBSTRUCTIVE AIRWAYS DISORDER 17 0.0015
468 ACUTE MYOCARDIAL INFARCTION 45 0.0015
469 DERMATITIS BULLOUS 11 0.0015
470 DIVERTICULITIS 42 0.0015
471 LIVER FUNCTION TEST ABNORMAL 44 0.0015
472 RECTAL HAEMORRHAGE 65 0.0015
473 SUDDEN DEATH 16 0.0015
474 BLOOD PRESSURE ABNORMAL 30 0.0015
475 URINARY RETENTION 50 0.0015
476 BLOOD PRESSURE INADEQUATELY CONTROLLED 9 0.0015
477 LEUKOCYTOSIS 27 0.0015
478 SOMNOLENCE 300 0.0015
479 ANHEDONIA 39 0.0015
480 NOCTURIA 18 0.0015
481 IMMUNOSUPPRESSION 13 0.0015
482 EPISTAXIS 109 0.0015
483 HYPOPHAGIA 37 0.0014
484 VISUAL ACUITY REDUCED 48 0.0014
485 HAEMORRHAGE 151 0.0014
486 LARGE INTESTINE PERFORATION 10 0.0014
487 NECROSIS 8 0.0014
488 BLOOD SODIUM DECREASED 27 0.0014
489 CARDIAC DISORDER 134 0.0014
490 CONDITION AGGRAVATED 435 0.0014
491 HEART RATE INCREASED 141 0.0014
492 HYPOALBUMINAEMIA 11 0.0014
493 CARDIO-RESPIRATORY ARREST 59 0.0014
494 CATARACT 84 0.0014
495 CIRCULATORY COLLAPSE 24 0.0014
496 DERMATITIS CONTACT 16 0.0014
497 RENAL DISORDER 65 0.0014
498 SOCIAL AVOIDANT BEHAVIOUR 8 0.0014
499 REFUSAL OF TREATMENT BY PATIENT 9 0.0014
500 ELECTROLYTE IMBALANCE 16 0.0014
501 URINE OUTPUT DECREASED 12 0.0014
502 WOUND INFECTION 15 0.0014
503 ALANINE AMINOTRANSFERASE INCREASED 84 0.0014
504 BLOOD PRESSURE DIASTOLIC DECREASED 10 0.0014
505 HYPERBILIRUBINAEMIA 14 0.0014
506 SKIN DISCOLOURATION 62 0.0013
507 BLINDNESS UNILATERAL 19 0.0013
508 BALANCE DISORDER 116 0.0013
509 ALTERED STATE OF CONSCIOUSNESS 29 0.0013
510 GANGRENE 8 0.0013
511 ABSCESS 21 0.0013
512 AORTIC ANEURYSM 10 0.0013
513 HAEMODIALYSIS 11 0.0013
514 VISUAL IMPAIRMENT 162 0.0013
515 FLUID OVERLOAD 19 0.0013
516 HYPERCALCAEMIA 16 0.0013
517 EYE PAIN 73 0.0013
518 URINARY INCONTINENCE 38 0.0013
519 DEHYDRATION 171 0.0013
520 SUBARACHNOID HAEMORRHAGE 13 0.0013
521 HEPATOCELLULAR INJURY 18 0.0013
522 HEAD INJURY 40 0.0013
523 CEREBRAL HAEMORRHAGE 45 0.0013
524 MACULAR DEGENERATION 15 0.0013
525 IMPAIRED QUALITY OF LIFE 18 0.0013
526 DRUG TOXICITY 17 0.0012
527 IRRITABILITY 75 0.0012
528 PNEUMONIA ASPIRATION 31 0.0012
529 CORONARY ARTERY OCCLUSION 17 0.0012
530 INTERVERTEBRAL DISC PROTRUSION 27 0.0012
531 FATIGUE 955 0.0012
532 CLOSTRIDIUM DIFFICILE COLITIS 13 0.0012
533 INTERNAL HAEMORRHAGE 14 0.0012
534 DIZZINESS 611 0.0012
535 PHOTOPHOBIA 23 0.0012
536 ANGINA PECTORIS 35 0.0012
537 MYOCARDITIS 14 0.0012
538 POLYURIA 10 0.0012
539 HICCUPS 10 0.0012
540 IMPAIRED HEALING 40 0.0012
541 GASTRIC HAEMORRHAGE 14 0.0012
542 TACHYCARDIA 108 0.0012
543 CONTUSION 117 0.0012
544 LIMB INJURY 33 0.0012
545 LUPUS-LIKE SYNDROME 11 0.0012
546 HYDRONEPHROSIS 9 0.0012
547 HEMIPLEGIA 10 0.0012
548 VISION BLURRED 165 0.0012
549 PALPITATIONS 140 0.0012
550 HYPERTENSION 253 0.0012
551 PRODUCTIVE COUGH 57 0.0012
552 TOXIC SKIN ERUPTION 12 0.0012
553 BACTERAEMIA 14 0.0012
554 OSTEOARTHRITIS 50 0.0012
555 PROCEDURAL COMPLICATION 9 0.0012
556 CELLULITIS 59 0.0012
557 INFARCTION 8 0.0012
558 FALL 389 0.0012
559 SQUAMOUS CELL CARCINOMA 11 0.0012
560 MUSCULOSKELETAL CHEST PAIN 18 0.0012
561 AGEUSIA 29 0.0012
562 MALNUTRITION 13 0.0012
563 PERITONITIS 24 0.0012
564 IMPAIRED DRIVING ABILITY 13 0.0011
565 MUSCULOSKELETAL STIFFNESS 100 0.0011
566 COLON CANCER 17 0.0011
567 ORAL CANDIDIASIS 15 0.0011
568 BLOOD ALBUMIN DECREASED 9 0.0011
569 CHRONIC KIDNEY DISEASE 86 0.0011
570 PURPURA 10 0.0011
571 DIALYSIS 16 0.0011
572 DIVERTICULUM 8 0.0011
573 WEIGHT DECREASED 314 0.0011
574 JOINT RANGE OF MOTION DECREASED 15 0.0011
575 RIB FRACTURE 23 0.0011
576 POST PROCEDURAL HAEMORRHAGE 13 0.0011
577 URINARY TRACT INFECTION 190 0.0011
578 HOSPICE CARE 11 0.0011
579 LETHARGY 64 0.0011
580 LACTIC ACIDOSIS 36 0.0011
581 MUSCLE DISORDER 9 0.0011
582 TACHYPNOEA 15 0.0011
583 HYPOKINESIA 16 0.0011
584 COVID-19 PNEUMONIA 13 0.0011
585 INCREASED APPETITE 21 0.0011
586 GINGIVAL BLEEDING 15 0.0011
587 METABOLIC ACIDOSIS 35 0.0011
588 VOMITING 509 0.0011
589 MUSCULAR WEAKNESS 122 0.0011
590 INITIAL INSOMNIA 11 0.0011
591 TUBULOINTERSTITIAL NEPHRITIS 20 0.0011
592 DEVICE OCCLUSION 15 0.0011
593 ISCHAEMIC STROKE 19 0.0011
594 CEREBRAL INFARCTION 26 0.0011
595 DYSARTHRIA 40 0.0011
596 EYE DISCHARGE 11 0.0011
597 BLOOD URINE PRESENT 20 0.0011
598 ABASIA 26 0.0011
599 RESPIRATORY ARREST 29 0.0011
600 CARDIAC OPERATION 9 0.0010
601 DECREASED APPETITE 243 0.0010
602 UNRESPONSIVE TO STIMULI 27 0.0010
603 POST PROCEDURAL COMPLICATION 20 0.0010
604 JAUNDICE 28 0.0010
605 OFF LABEL USE 910 0.0010
606 SINUS CONGESTION 14 0.0010
607 APNOEA 8 0.0010
608 GASTROINTESTINAL DISORDER 92 0.0010
609 GASTRITIS 27 0.0010
610 HAEMATEMESIS 26 0.0010
611 PARKINSONISM 10 0.0010
612 TUMOUR LYSIS SYNDROME 9 0.0010
613 MULTIPLE ALLERGIES 8 0.0010
614 PANCYTOPENIA 57 0.0010
615 HEPATIC CYTOLYSIS 13 0.0010
616 DECREASED ACTIVITY 11 0.0010
617 GAIT INABILITY 34 0.0010
618 MYOCARDIAL INFARCTION 177 0.0010
619 RESPIRATORY RATE INCREASED 9 0.0010
620 INJURY 71 0.0010
621 SINUS DISORDER 20 0.0010
622 DISORIENTATION 40 0.0010
623 CONFUSIONAL STATE 163 0.0010
624 BLADDER DISORDER 10 0.0010
625 SKIN ULCER 26 0.0010
626 HAEMOGLOBIN DECREASED 103 0.0010
627 DRY EYE 50 0.0010
628 BLOOD PRESSURE FLUCTUATION 24 0.0010
629 BLOOD DISORDER 8 0.0010
630 DEAFNESS 26 0.0010
631 SENSORY LOSS 8 0.0010
632 STENT PLACEMENT 8 0.0010
633 CHOLESTASIS 19 0.0010
634 FEEDING DISORDER 20 0.0010
635 MOTOR DYSFUNCTION 10 0.0010
636 SKIN INFECTION 11 0.0010
637 PNEUMONIA BACTERIAL 9 0.0010
638 OCULAR DISCOMFORT 11 0.0010
639 BLOOD CALCIUM DECREASED 11 0.0010
640 PLATELET COUNT DECREASED 104 0.0010
641 DELUSION 15 0.0010
642 RESPIRATORY TRACT INFECTION 25 0.0010
643 GASTROENTERITIS 14 0.0010
644 PALLOR 26 0.0010
645 HALLUCINATION, VISUAL 20 0.0009
646 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 45 0.0009
647 BODY HEIGHT DECREASED 10 0.0009
648 GLAUCOMA 18 0.0009
649 HALLUCINATION 70 0.0009
650 BLOOD IRON DECREASED 11 0.0009
651 DEPRESSION 208 0.0009
652 HEPATIC ENZYME INCREASED 62 0.0009
653 RED BLOOD CELL COUNT DECREASED 26 0.0009
654 PHOTOSENSITIVITY REACTION 15 0.0009
655 HYPERGLYCAEMIA 33 0.0009
656 NERVE INJURY 10 0.0009
657 HYPOCALCAEMIA 17 0.0009
658 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 23 0.0009
659 PERICARDITIS 15 0.0009
660 GASTROINTESTINAL INFECTION 8 0.0009
661 BRONCHITIS 66 0.0009
662 MYOSITIS 8 0.0009
663 HYPOTHERMIA 9 0.0009
664 CHEST DISCOMFORT 91 0.0009
665 SYNOVITIS 16 0.0009
666 DRY THROAT 9 0.0009
667 ILEUS 11 0.0009
668 OPTIC NEURITIS 8 0.0009
669 SKIN HAEMORRHAGE 13 0.0009
670 PERIPHERAL COLDNESS 12 0.0009
671 RETINAL DETACHMENT 8 0.0009
672 RESPIRATORY DISORDER 26 0.0009
673 BLOOD CREATINE PHOSPHOKINASE INCREASED 25 0.0009
674 THERAPY NON-RESPONDER 39 0.0009
675 TENDERNESS 9 0.0009
676 MOBILITY DECREASED 62 0.0009
677 PETECHIAE 9 0.0009
678 PRODUCT DISTRIBUTION ISSUE 8 0.0009
679 APHASIA 26 0.0009
680 HEPATIC STEATOSIS 16 0.0009
681 SPEECH DISORDER 45 0.0009
682 CONTRAINDICATED PRODUCT ADMINISTERED 26 0.0009
683 LOSS OF CONSCIOUSNESS 110 0.0009
684 THROMBOCYTOPENIA 96 0.0009
685 FEAR 23 0.0009
686 VERTIGO 52 0.0009
687 LACERATION 8 0.0008
688 LEUKAEMIA 8 0.0008
689 DIPLOPIA 22 0.0008
690 DRUG ERUPTION 15 0.0008
691 INFUSION RELATED REACTION 56 0.0008
692 NAUSEA 668 0.0008
693 CHOLECYSTITIS 10 0.0008
694 SKIN LESION 23 0.0008
695 HYPERSOMNIA 24 0.0008
696 BEDRIDDEN 11 0.0008
697 DYSKINESIA 34 0.0008
698 HERPES ZOSTER 48 0.0008
699 POLYNEUROPATHY 10 0.0008
700 CYANOSIS 13 0.0008
701 ASTHMA 93 0.0008
702 APATHY 12 0.0008
703 RESPIRATORY TRACT CONGESTION 13 0.0008
704 OBESITY 13 0.0008
705 LABORATORY TEST ABNORMAL 24 0.0008
706 HYPERTENSIVE CRISIS 9 0.0008
707 ACTIVITIES OF DAILY LIVING IMPAIRED 16 0.0008
708 PERIPHERAL SWELLING 124 0.0008
709 DYSPHONIA 47 0.0008
710 EYE IRRITATION 46 0.0008
711 STATUS EPILEPTICUS 9 0.0008
712 EMPHYSEMA 8 0.0008
713 FRACTURE 15 0.0008
714 DYSSTASIA 23 0.0008
715 GENERALISED TONIC-CLONIC SEIZURE 13 0.0008
716 SLUGGISHNESS 8 0.0008
717 WHITE BLOOD CELL COUNT INCREASED 30 0.0008
718 EAR DISCOMFORT 8 0.0008
719 SINUS TACHYCARDIA 11 0.0008
720 RESTLESS LEGS SYNDROME 14 0.0008
721 HAEMORRHOIDS 15 0.0008
722 SPLENOMEGALY 9 0.0008
723 SPINAL PAIN 9 0.0008
724 STAPHYLOCOCCAL INFECTION 25 0.0008
725 COMPLICATION ASSOCIATED WITH DEVICE 11 0.0008
726 BLOOD LACTATE DEHYDROGENASE INCREASED 12 0.0008
727 AGRANULOCYTOSIS 14 0.0008
728 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 41 0.0007
729 HIP FRACTURE 24 0.0007
730 EYE DISORDER 24 0.0007
731 NEUROPATHY PERIPHERAL 69 0.0007
732 INSURANCE ISSUE 11 0.0007
733 RASH MACULO-PAPULAR 16 0.0007
734 WEIGHT INCREASED 161 0.0007
735 CHROMATURIA 16 0.0007
736 BLOOD PRESSURE INCREASED 108 0.0007
737 RETCHING 15 0.0007
738 HEPATITIS 18 0.0007
739 CHOLELITHIASIS 23 0.0007
740 CYTOKINE RELEASE SYNDROME 14 0.0007
741 PRODUCT ADMINISTRATION ERROR 14 0.0007
742 FAECES DISCOLOURED 15 0.0007
743 PRODUCT PRESCRIBING ISSUE 15 0.0007
744 HAEMATOCHEZIA 38 0.0007
745 HYPERHIDROSIS 88 0.0007
746 FEELING COLD 19 0.0007
747 COLD SWEAT 12 0.0007
748 DEMENTIA 19 0.0007
749 DYSURIA 25 0.0007
750 ADVERSE DRUG REACTION 61 0.0007
751 LYMPHOCYTE COUNT DECREASED 12 0.0007
752 HEAD DISCOMFORT 12 0.0007
753 DIABETES MELLITUS INADEQUATE CONTROL 12 0.0007
754 STEVENS-JOHNSON SYNDROME 15 0.0007
755 NERVOUS SYSTEM DISORDER 21 0.0007
756 OSTEOMYELITIS 12 0.0007
757 ACCIDENTAL OVERDOSE 24 0.0007
758 DYSPHAGIA 62 0.0007
759 PRESCRIBED UNDERDOSE 13 0.0007
760 HYPOACUSIS 28 0.0006
761 ANXIETY 185 0.0006
762 GASTROOESOPHAGEAL REFLUX DISEASE 52 0.0006
763 CARPAL TUNNEL SYNDROME 9 0.0006
764 TREATMENT NONCOMPLIANCE 35 0.0006
765 LYMPHOPENIA 9 0.0006
766 DERMATITIS ALLERGIC 8 0.0006
767 BRAIN OEDEMA 8 0.0006
768 CEREBROVASCULAR ACCIDENT 107 0.0006
769 GASTRIC ULCER 12 0.0006
770 SCIATICA 10 0.0006
771 POLLAKIURIA 26 0.0006
772 ANOREXIA 8 0.0006
773 DYSPEPSIA 61 0.0006
774 MOUTH ULCERATION 13 0.0006
775 PLATELET COUNT INCREASED 8 0.0006
776 KIDNEY INFECTION 12 0.0006
777 BACK PAIN 142 0.0006
778 WOUND 17 0.0006
779 DEPRESSED LEVEL OF CONSCIOUSNESS 24 0.0006
780 RHINORRHOEA 39 0.0006
781 UPPER LIMB FRACTURE 12 0.0006
782 VIRAL INFECTION 20 0.0006
783 PAIN IN JAW 17 0.0006
784 FUNGAL INFECTION 20 0.0006
785 AMNESIA 39 0.0006
786 PYREXIA 207 0.0006
787 LACRIMATION INCREASED 18 0.0006
788 FULL BLOOD COUNT DECREASED 12 0.0006
789 PRODUCT PHYSICAL ISSUE 12 0.0006
790 HYPOAESTHESIA 89 0.0006
791 HEMIPARESIS 10 0.0006
792 MIDDLE INSOMNIA 11 0.0006
793 NEPHROLITHIASIS 27 0.0006
794 HEADACHE 369 0.0006
795 COMA 28 0.0006
796 TINNITUS 27 0.0006
797 THERAPY CESSATION 30 0.0006
798 SCAR 10 0.0006
799 FLATULENCE 33 0.0006
800 LIMB DISCOMFORT 18 0.0006
801 FEMUR FRACTURE 18 0.0006
802 MUSCULOSKELETAL DISCOMFORT 10 0.0006
803 PROSTATIC SPECIFIC ANTIGEN INCREASED 8 0.0006
804 ORAL PAIN 13 0.0006
805 PARANOIA 10 0.0006
806 SNEEZING 13 0.0006
807 ANAPHYLACTIC REACTION 32 0.0006
808 DRUG INEFFECTIVE 763 0.0006
809 LOCALISED INFECTION 14 0.0006
810 C-REACTIVE PROTEIN INCREASED 21 0.0006
811 THERAPY PARTIAL RESPONDER 9 0.0006
812 RASH PRURITIC 31 0.0006
813 DEVICE USE ISSUE 10 0.0006
814 PRODUCT USE COMPLAINT 9 0.0006
815 INSOMNIA 152 0.0006
816 OCULAR HYPERAEMIA 27 0.0006
817 DIARRHOEA 363 0.0006
818 INTENTIONAL DOSE OMISSION 16 0.0006
819 THIRST 10 0.0006
820 ARTHRITIS 44 0.0006
821 COGNITIVE DISORDER 26 0.0006
822 TREATMENT FAILURE 46 0.0006
823 BLISTER 31 0.0006
824 THERAPEUTIC RESPONSE DECREASED 33 0.0005
825 TASTE DISORDER 11 0.0005
826 TOOTH DISORDER 12 0.0005
827 EYE SWELLING 20 0.0005
828 ABDOMINAL DISCOMFORT 90 0.0005
829 MENTAL IMPAIRMENT 13 0.0005
830 CANDIDA INFECTION 9 0.0005
831 PRODUCT DOSE OMISSION ISSUE 156 0.0005
832 PAIN IN EXTREMITY 155 0.0005
833 FEELING HOT 32 0.0005
834 FLUSHING 53 0.0005
835 INFECTION 75 0.0005
836 HERNIA 10 0.0005
837 WHITE BLOOD CELL COUNT DECREASED 56 0.0005
838 LOCAL SWELLING 9 0.0005
839 LUNG INFECTION 8 0.0005
840 HOSPITALISATION 79 0.0005
841 JOINT SWELLING 62 0.0005
842 METASTASES TO LIVER 9 0.0005
843 SKIN CANCER 11 0.0005
844 ALOPECIA 100 0.0005
845 ABDOMINAL PAIN UPPER 104 0.0005
846 GALLBLADDER DISORDER 9 0.0005
847 MEDICATION ERROR 28 0.0005
848 BLOOD GLUCOSE DECREASED 24 0.0005
849 OROPHARYNGEAL PAIN 46 0.0005
850 NIGHT SWEATS 16 0.0005
851 ILL-DEFINED DISORDER 30 0.0005
852 MALAISE 215 0.0005
853 COVID-19 86 0.0005
854 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 88 0.0005
855 DEATH 419 0.0005
856 RASH MACULAR 17 0.0005
857 PAIN 298 0.0005
858 DYSGEUSIA 36 0.0005
859 EXTRAPYRAMIDAL DISORDER 12 0.0005
860 THINKING ABNORMAL 9 0.0005
861 SURGERY 28 0.0005
862 PARAESTHESIA 75 0.0005
863 INFLUENZA 53 0.0005
864 PROTEINURIA 9 0.0005
865 LOWER LIMB FRACTURE 9 0.0005
866 IRRITABLE BOWEL SYNDROME 10 0.0005
867 PRESCRIBED OVERDOSE 9 0.0005
868 POOR QUALITY SLEEP 10 0.0005
869 NEUTROPENIA 63 0.0005
870 BLOOD PRESSURE SYSTOLIC INCREASED 9 0.0005
871 SKIN FISSURES 9 0.0005
872 RASH ERYTHEMATOUS 22 0.0005
873 DEVICE DISLOCATION 20 0.0005
874 INTESTINAL OBSTRUCTION 17 0.0005
875 NECK PAIN 25 0.0004
876 GASTROENTERITIS VIRAL 8 0.0004
877 NASAL CONGESTION 26 0.0004
878 OSTEOPOROSIS 18 0.0004
879 ILLNESS 45 0.0004
880 MOVEMENT DISORDER 14 0.0004
881 AGITATION 32 0.0004
882 ARTHRALGIA 181 0.0004
883 FEELING ABNORMAL 104 0.0004
884 ROAD TRAFFIC ACCIDENT 18 0.0004
885 ANAPHYLACTIC SHOCK 11 0.0004
886 DISCOMFORT 26 0.0004
887 IMPAIRED WORK ABILITY 9 0.0004
888 MUSCULOSKELETAL PAIN 22 0.0004
889 SINUSITIS 43 0.0004
890 EYE PRURITUS 14 0.0004
891 PANCREATITIS 22 0.0004
892 MENTAL DISORDER 18 0.0004
893 LUNG NEOPLASM MALIGNANT 17 0.0004
894 HOT FLUSH 31 0.0004
895 PRODUCT USE ISSUE 76 0.0004
896 CHILLS 47 0.0004
897 MYALGIA 68 0.0004
898 SPINAL FRACTURE 8 0.0004
899 NASOPHARYNGITIS 73 0.0004
900 ARTHROPATHY 22 0.0004
901 COLITIS 15 0.0004
902 ABDOMINAL PAIN LOWER 10 0.0004
903 HYPERSENSITIVITY 73 0.0004
904 MEMORY IMPAIRMENT 54 0.0004
905 NEUTROPHIL COUNT DECREASED 16 0.0004
906 BODY TEMPERATURE INCREASED 8 0.0004
907 FEBRILE NEUTROPENIA 26 0.0004
908 EMOTIONAL DISORDER 12 0.0004
909 BLOOD GLUCOSE INCREASED 73 0.0004
910 PHARMACEUTICAL PRODUCT COMPLAINT 10 0.0004
911 BURNING SENSATION 27 0.0004
912 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 13 0.0004
913 PANIC ATTACK 14 0.0004
914 MUCOSAL INFLAMMATION 10 0.0004
915 JOINT STIFFNESS 10 0.0004
916 EMOTIONAL DISTRESS 46 0.0004
917 LEUKOPENIA 19 0.0004
918 THERAPY INTERRUPTED 27 0.0004
919 NIGHTMARE 13 0.0004
920 PSYCHOTIC DISORDER 11 0.0004
921 MUSCLE SPASMS 68 0.0004
922 DEVICE MALFUNCTION 26 0.0004
923 PRURITUS 142 0.0004
924 GLOSSODYNIA 8 0.0004
925 TYPE 2 DIABETES MELLITUS 12 0.0004
926 PANCREATITIS ACUTE 8 0.0004
927 ERYTHEMA 73 0.0004
928 DEEP VEIN THROMBOSIS 23 0.0004
929 RASH GENERALISED 9 0.0003
930 MUSCLE TWITCHING 8 0.0003
931 CYSTITIS 11 0.0003
932 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 8 0.0003
933 UNDERDOSE 25 0.0003
934 RASH 148 0.0003
935 DRY SKIN 45 0.0003
936 DISEASE RECURRENCE 16 0.0003
937 OVERDOSE 72 0.0003
938 INFLAMMATION 17 0.0003
939 FIBROMYALGIA 8 0.0003
940 EPILEPSY 10 0.0003
941 ABNORMAL DREAMS 9 0.0003
942 GASTRIC DISORDER 11 0.0003
943 DISEASE PROGRESSION 37 0.0003
944 ERECTILE DYSFUNCTION 8 0.0003
945 RHEUMATOID ARTHRITIS 35 0.0003
946 SWELLING FACE 20 0.0003
947 ABNORMAL BEHAVIOUR 12 0.0003
948 DEPRESSED MOOD 16 0.0003
949 DEVICE LEAKAGE 13 0.0003
950 PAIN OF SKIN 8 0.0003
951 STOMATITIS 18 0.0003
952 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 21 0.0003
953 ECZEMA 15 0.0003
954 INTENTIONAL PRODUCT USE ISSUE 25 0.0003
955 INCORRECT DOSE ADMINISTERED 65 0.0003
956 AGGRESSION 14 0.0003
957 ADVERSE EVENT 25 0.0003
958 CONVULSION 15 0.0003
959 SKIN EXFOLIATION 22 0.0003
960 DRUG ADMINISTRATION ERROR 8 0.0003
961 GYNAECOMASTIA 8 0.0003
962 BONE PAIN 15 0.0003
963 COMPLETED SUICIDE 21 0.0003
964 INTENTIONAL OVERDOSE 16 0.0002
965 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 50 0.0002
966 THROAT IRRITATION 11 0.0002
967 DRUG ABUSE 20 0.0002
968 PLASMA CELL MYELOMA 9 0.0002
969 LYMPHADENOPATHY 8 0.0002
970 SEIZURE 26 0.0002
971 MIGRAINE 21 0.0002
972 SKIN IRRITATION 10 0.0002
973 NEOPLASM MALIGNANT 14 0.0002
974 VAGINAL HAEMORRHAGE 9 0.0002
975 PRODUCT QUALITY ISSUE 28 0.0002
976 ANGIOEDEMA 9 0.0002
977 INFLUENZA LIKE ILLNESS 16 0.0002
978 URTICARIA 31 0.0002
979 EXPOSURE DURING PREGNANCY 11 0.0002
980 MULTIPLE SCLEROSIS 8 0.0002
981 DRUG EFFECT DECREASED 9 0.0002
982 MALIGNANT NEOPLASM PROGRESSION 17 0.0002
983 PROSTATE CANCER 13 0.0002
984 INJECTION SITE SWELLING 12 0.0002
985 INJECTION SITE HAEMORRHAGE 12 0.0002
986 INJECTION SITE PAIN 46 0.0001
987 DEVICE ISSUE 12 0.0001
988 PSORIASIS 17 0.0001
989 PRODUCT DOSE OMISSION 8 0.0001
990 INJECTION SITE ERYTHEMA 15 0.0001
991 BREAST CANCER 11 0.0001
992 DRUG DOSE OMISSION 19 0.0001
993 INJECTION SITE BRUISING 9 0.0001
994 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 8 0.0001
995 SUICIDAL IDEATION 10 0.0001
996 ACCIDENTAL EXPOSURE TO PRODUCT 9 0.0001
997 NO ADVERSE EVENT 15 0.0001